banner
BTK inhibitor PCI-32765, Purity ≥98%
Inquiry

Cat. No.: X24-06-ZQ495

BTK inhibitor PCI-32765, Purity ≥98%

Synonym: 936563-96-1; BTK inhibitor; Ibrutinib

  • MDL: MFCD20261150
  • CAS Number: 936563-96-1
  • Compound CID: 24821094
img
Product Size
10 mg; 25 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
PCI-32765, soluble in DMSO and ethanol and insoluble in water, is a compound designed to block Bruton’s tyrosine kinase (BTK), an enzyme essential for the proliferation and survival of certain cancerous B cells. It targets BLK, BMX, Abl, BRK, BTK, c-Src, CSK, EGFR, ErbB2, FER, and FGR.
Molecular Weight
440.5
Molecular Formula
C25H24N6O2
Targets
BLK: 0.5 nM; BMX: 0.8 nM; Abl: 86 nM; BRK: 3.3 nM; BTK: 0.5 nM; c-Src: 171 nM; CSK: 2.3 nM; EGFR: 5.6 nM; ErbB2: 9.4 nM; FER: 8.07 nM; FGR: 2.3 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 81 mg/mL (183.88 mM); Water: Insoluble; Ethanol: 41 mg/mL (93.07 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
PCI-32765 also known as Ibrutinib, is a BTK inhibitor with applications in cancer research.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0